Summary

Article Metadata

Madrigal Pharmaceuticals Shares Plunge

This is a U.S. news story, published by Yahoo Finance, that relates primarily to ET news.

U.S. news

For more U.S. news, you can click here:

ET news

For more ET news, you can click here:

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

Yahoo Finance news

For more news from Yahoo Finance, you can click here:

more news from Yahoo Finance

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

Madrigal Pharmaceuticals stock

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Madrigal Pharmaceuticals news, Madrigal news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

Buy Madrigal Pharmaceuticals stock

The Motley Fool

The Motley Fool

•

Why Madrigal Pharmaceuticals Stock Is Sinking Today

The Motley Fool

Summary

Nutrition label

65% Informative

Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were sinking 13.3% lower as of 11:11 a.m. ET on Monday .

The sell-off came after the drugmaker announced its preliminary fourth-quarter and full-year 2024 results.

Rezadiffra is only in the early stages of its U.S. launch.

VR Score

49

Informative language

40

Neutral language

8

Article tone

informal

Language

English

Language complexity

40

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

6

https://www.fool.com/author/2035/https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=50a1c0d3-a39e-474c-ac9b-9351c034a7f2&url=https%3A%2F%2Fwww.fool.com%2Fmms%2Fmark%2Fa-sa-dd-3%3Faid%3D9431%26source%3Disaeditxt0010984%26ftm_cam%3Dsa-dd%26ftm_pit%3D16623%26ftm_veh%3Darticle_pitch_feed_yahoo&utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=bb814bd5-9a57-44e3-bbf0-9eb9df81d375 https://www.fool.com/legal/fool-disclosure-policy/https://www.fool.com/investing/stock-market/market-sectors/healthcare/biotech-stocks/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=bb814bd5-9a57-44e3-bbf0-9eb9df81d375 https://api.fool.com/infotron/infotrack/click?apikey=35527423-a535-4519-a07f-20014582e03e&impression=50a1c0d3-a39e-474c-ac9b-9351c034a7f2&url=https%3A%2F%2Fwww.fool.com%2Fmms%2Fmark%2Fa-sa-dd-3%3Faid%3D9431%26source%3Disaeditxt0010984%26ftm_cam%3Dsa-dd%26ftm_veh%3Darticle_pitch_feed_yahoo%26ftm_pit%3D16623&utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=bb814bd5-9a57-44e3-bbf0-9eb9df81d375 https://www.fool.com/investing/2025/01/13/why-madrigal-pharmaceuticals-stock-is-sinking-toda/?utm_source=yahoo-host-full&utm_medium=feed&utm_campaign=article&referring_guid=bb814bd5-9a57-44e3-bbf0-9eb9df81d375

Source diversity

2

www.fool.com api.fool.com

Affiliate links

no affiliate links

Read full article